2Hod WH. Hypertension in end-stage renal disease:different measures and their prognostic significance [J]. Nephrol Dial Tran splant,2010,25(10) :3161-3166.
3Tomic M, Galesic K, Markota I. Endothelin-1 and nitric oxide in patients on chronic hemodialysis [J]. Ren Fail,2008,30(9) : 836-842.
4Tomic, Galesic K,Markota I. Enclothelin-1 and nitric oxide in patientson chronic hemodialysis [J]. Ren Fail, 2008,30(9) :836- 842.
5Loukanov T, Arnold R, Gross J,et al. Endothelin-1 and asym- metric dimethylarginine in children with left-to-right shunt af- ter intracardiac repair [J]. Clin Res Cardiol, 2008,97 (6) : 383- 388.
6Voroneanu L The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients:use of bioimpedance provides a different perspective from echocar- diography and biomarker methodologies [J]. Int Urol Nephrol, 2010,42(3) :789-797.
7Inrig JK,Patel UD,Gillespie BS,et al. Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients [J]. Am J Kidney Dis,2007,50(1) : 108- 118.
8Van Buren PN, Kim C,Toto R, et al. Intradialytic hypertension and the association with interdialytic ambulatory blood pres- sure [J]. Clin J Am Soc Nephrol,2011,6(7) :1684-1691.
9Shavit L. Effect of eplerenone on blood pressure and the renin- angiotensin- aldosterone system in oligo-anuric chronic hemo dialysis patients -a pilot study [J]. Clin Nephrol,2011,76(5): 388-395.
10Di Daniele N,De Francesco M,Violo L,et al. Simonetti G Renal sympathetic nerve ablation for the treatment of difficult- to-control or refractory hypertension in a haemodialysis patient [J]. Nephrol Dial Transplant, 2012,27 (4) : 1689-1690.
